The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

As Covid cases are ramping up once again this summer, it’s natural to start thinking of the risks and wonder if it’s time to ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two COVID-19 vaccines.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

The new shots won’t be available until the fall, and are expected to be approved only for adults 65 and up and kids and ...

Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children ...

Fresh off of the heels of a shakeup at the CDC over vaccine recommendations, many Americans still question the necessity and safety of COVID-19 vaccines for young children.

FDA grants full approval to Moderna's COVID-19 vaccine for children aged 6 months to 11 years with medical vulnerabilities, marking a shift from emergency use to selective eligibility.

The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second option.

WASHINGTON — The government’s top vaccine official working under Health Secretary Robert F. Kennedy Jr. recently restricted the approval of two covid-19 vaccines, disregarding recommendations ...